Literature DB >> 8176213

Role of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands.

K W Marshall1, A F Liu, J Canales, B Perahia, B Jorgensen, R D Gantzos, B Aguilar, B Devaux, J B Rothbard.   

Abstract

Analysis of peptide binding to a set of HLA-DR alleles has allowed the proteins to be segregated into functional subsets, depending on the amino acids at positions 57 and 86 of the beta-chain. DR proteins with glycine at 86 beta and aspartic acid at 57 beta bound a simplified peptide with significantly lower IC50 values than alleles that did not have this combination of amino acids. The size of the amino acid at 86 beta seemed to modify the steric requirements for the single most important side chain of the peptide. Within each of the four subgroups, other polymorphic amino acids define allele-specific binding requirements. These were explored by analyzing the ability of eight different DR alleles to bind 13 known T cell determinants. The side chains in the peptides that seemed to be responsible for allele specificity were determined by correlating their common structural features with complementary polymorphic residues in the binding site. The importance of these residues was tested by incorporating them into a polyalanine backbone, and was confirmed by the ability of these residues to transfer allele specificity to these simplified analogues. Even though polymorphic contacts affected peptide affinity, the majority of the free energy of binding in all cases arose from interactions with the peptide backbone and the single hydrophobic amino acid at the third position. These constraints seem to orient all peptides in a similar location, forcing them to adopt a closely related conformation in the binding site. The corresponding side chain in each peptide contacts the same pocket in the binding site, regardless of the allele. This apparent similarity should allow any DR allele to be analyzed by extrapolation from the DR1 crystal structure.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8176213

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  A novel predictive technique for the MHC class II peptide-binding interaction.

Authors:  Matthew N Davies; Clare E Sansom; Claude Beazley; David S Moss
Journal:  Mol Med       Date:  2003 Sep-Dec       Impact factor: 6.354

2.  Quantitative analysis of peptides from myelin basic protein binding to the MHC class II protein, I-Au, which confers susceptibility to experimental allergic encephalomyelitis.

Authors:  L Fugger; J Liang; A Gautam; J B Rothbard; H O McDevitt
Journal:  Mol Med       Date:  1996-03       Impact factor: 6.354

3.  Critical contribution of beta chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules.

Authors:  B S Nepom; G T Nepom; M Coleman; W W Kwok
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

4.  Measurement of MHC/peptide interactions by gel filtration or monoclonal antibody capture.

Authors:  John Sidney; Scott Southwood; Carrie Moore; Carla Oseroff; Clemencia Pinilla; Howard M Grey; Alessandro Sette
Journal:  Curr Protoc Immunol       Date:  2013-02

5.  Natural peptides isolated from Gly86/Val86-containing variants of HLA-DR1, -DR11, -DR13, and -DR52.

Authors:  F A Verreck; A van de Poel; J W Drijfhout; R Amons; J E Coligan; F Konig
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

6.  Differences in self-peptide binding between T1D-related susceptible and protective DR4 subtypes.

Authors:  Xinhui Ge; Eddie A James; Helena Reijonen; William W Kwok
Journal:  J Autoimmun       Date:  2011-01-22       Impact factor: 7.094

7.  Identification and antigenicity of broadly cross-reactive and conserved human immunodeficiency virus type 1-derived helper T-lymphocyte epitopes.

Authors:  C C Wilson; B Palmer; S Southwood; J Sidney; Y Higashimoto; E Appella; R Chesnut; A Sette; B D Livingston
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

8.  Polymorphic structural features of modelled HLA-DQ molecules segregate according to susceptibility or resistance to IDDM.

Authors:  J Routsias; G K Papadopoulos
Journal:  Diabetologia       Date:  1995-11       Impact factor: 10.122

9.  Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DR beta chain.

Authors:  M P Davenport; C L Quinn; R M Chicz; B N Green; A C Willis; W S Lane; J I Bell; A V Hill
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

10.  T cell subsets, epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis.

Authors:  B Chauhan; A p Knutsen; P S Hutcheson; R G Slavin; C J Bellone
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.